ASSET PURCHASE AND LICENSE AGREEMENT BETWEEN AVANIR PHARMACEUTICALS INC. XENEREX BIOSCIENCES INC. EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC. AND EMERGENT BIOSOLUTIONS INC. Dated as of March 6, 2008Asset Purchase and License Agreement • May 14th, 2008 • Avanir Pharmaceuticals • Pharmaceutical preparations • New York
This Asset Purchase and License Agreement is entered into as of March 6, 2008 (the “Agreement”) by and between Emergent Product Development Gaithersburg Inc., a Delaware corporation (“Buyer”), Emergent BioSolutions Inc., a Delaware corporation (“Buyer Parent”), Avanir Pharmaceuticals Inc., a California corporation (“Seller Parent”), and Xenerex Biosciences Inc., a California corporation (“Seller” and, together with Seller Parent, the “Sellers”). Each party to this Agreement is sometimes referred to herein as a “Party” or collectively, the “Parties.” Capitalized terms used in this Agreement shall have the meanings ascribed to them where defined or in Article IX.
